Zika vaccine shows promise in early human trial

CHICAGO (Reuters) - A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news